Cell-free Assays (IC50/Ki) for Pirfenidone
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| TGF-β protein | 7.08 μm | Molecular docking study using AutoDock Tools 1.5.6 | Download PDF |
| TNF-α | 22.81 μm | Molecular docking study using AutoDock Tools 1.5.6 | Download PDF |
Cell-based Assay (IC50) for Pirfenidone
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| A549 cells | 72.13 ± 3.29 µmol/L | MTT assay | PMC11968824 |
| MRC-5 cell line | 211.9 µg/ml | MTT assay | Download PDF |
| LX-2 | 10.74 mM | MTT assay | Download PDF |
| normal human lung fibroblasts | 147 µM | Western blot | PMC10133585 |
| IPF human lung fibroblasts | 118 µM | Western blot | PMC10133585 |
| fibrotic mouse lung PCLSs | 678 µM | Col1a1 mRNA level reduction by 50% | Download PDF |
| A549 | 1.5 x 10^3 µM | Sulforhodamine B (SRB) assay, interpolation on dose-response curves | Download PDF |
| NCI-H322 | 2.8 x 10^3 µM | Sulforhodamine B (SRB) assay, interpolation on dose-response curves | Download PDF |
| NCI-H460 | 1.9 x 10^3 µM | Sulforhodamine B (SRB) assay, interpolation on dose-response curves | Download PDF |
| CAFs | 534.5 ± 24.48 µg/ml | MTT assay | PMC12923477 |
Check the
Pirfenidone
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Pirfenidone Mechanism of Action: TGF-β Inhibition in Lung Fibroblast Research
- Pirfenidone Clinical Trials
- Pirfenidone Working Concentration | Cell Culture | Treatment
- Pirfenidone Solubility in DMSO
- Pirfenidone Stock Solution
- Pirfenidone Storage
- Pirfenidone Stability
- Pirfenidone Combination Database
- Pirfenidone Molecular Weight
- Pirfenidone SMILES
- Pirfenidone CAS Number
- Pirfenidone Chemical Structure (2D and 3D)
- Pirfenidone APExBIO (B2288)? Try a better option.
- Pirfenidone MedChemExpress (HY-B0673)? Try a better option.
- Pirfenidone Sigma (P2116)? Try a better option.
- Pirfenidone SDS|MSDS